UroGen Pharma Ltd. URGN
NASDAQ · United States · Health Technology
$40.32-0.32 (-0.78%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $42.52 | -5.19% · below |
| 50-period average | $43.86 | -8.07% · below |
| 200-period average | $29.83 | +35.13% · above |
| Avg. volume (1Y) | 864.76K |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.